. Study of serum 3,5,3\m='\-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol 1996;134:45-9. Sulfation is an important pathway of triiodothyronine (T3) 
positive correlation was observed between T3S and TBG values. The T3S/FT3 ratio was higher both in CRF (18 \m=+-\5) and in ESND (23 \m=+-\18) as compared to controls (10 \ m=+-\4). Serum inorganic sulfate was increased and correlated positively with T3S values in CRF patients. In conclusion, the results of this study in a large series of patients confirm that patients with systemic non-thyroidal illness have increased serum T3S levels. The mechanisms responsible for these changes appear to be different in ESND and CRF patients. In ESND the increase in serum T3S levels is mainly related to reduced degradation of the hormone by type I MD, whereas in CRF it might be driven by the enhanced sulfate ion concentration, and could be partially dependent on the impaired renal excretion of T3S Because T3S can be reconverted to T3. it is possible that increased T3S concentrations contribute to maintenance of the euthyroid state in systemic non-thyroidal disease. Ferruccio Santini (4, 5) . These pathways explain the thyromimetic effect of T3S when injected in rats (6 (Fig. 2) .
Serum T3S and TBG concentrations were correlated directly in the CRF group (r = 0.4, < 0.005) but not in the ESND group (Fig. 3) . With Increased serum T3S concentration has been reported in some patients with systemic non-thyroidal illness, but the mechanisms responsible for this increase have not been investigated (1). In these patients, significant alterations in the production, distribution and metabo¬ lism of thyroid hormones are observed, in the absence of underlying disorders of the hypothalamus, pituitary or thyroid gland (17 (17) .
In the present study changes in serum T3S levels were investigated in two types of severe non-thyroidal illness (ESND and CRF). (26) . A decreased TSH secretion with a loss of the nocturnal TSH surge has also been described (27) (28, 29) . However, the amount of T3S in the glomerular filtrate could be greater than that found in the urine, due to re-absorbtion and subsequent deiodination of T3S at the tubular level, in a manner similar to that proposed for other iodothyronines (30) . Indeed, kidney tissue exhibits high levels of type I MD activity, and the type I MD mRNA has been localized to the kidney proximal tubule (31) . Therefore, the glomerular filtration rate could be more important for the clearance of T3S than would be estimated by measuring the T5S concentration in urine. The increase of T3S might also be driven by the elevated serum concentration of inorganic sulphate, which in uremie patients results from a decreased renal excretion of this ion (32) . The 
